Literature DB >> 2291116

Valuation of health states by the general public: feasibility of a standardized measurement procedure.

M L Essink-Bot1, G J Bonsel, P J van der Maas.   

Abstract

In the context of an international collaborative study we tested the feasibility of a utility measurement procedure in the Dutch general population. A postal questionnaire was sent to a random sample of 200 households in a town in the Netherlands (+/- 50,000 inh.). Respondents were requested to value 14 six-dimensional health states by means of visual analogue scaling (VAS). The response was satisfactory (57%), though about a fifth of those willing to complete the questionnaire did not manage to use a VAS to express their opinion. Inconsistent answers occurred relatively seldom. Generally consensus existed with regard to relative (ranking) and absolute values of different health states. These first results encourage us to go on with the development of this international instrument for the valuation of health states. We conclude the present instrument to be a feasible tool for valuation research, although questions relating to its measuring properties, as well as its reliability and validity remain to be answered.

Mesh:

Year:  1990        PMID: 2291116     DOI: 10.1016/0277-9536(90)90124-b

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  10 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 2.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

3.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

4.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

5.  Health state valuations from the general public using the visual analogue scale.

Authors:  C Gudex; P Dolan; P Kind; A Williams
Journal:  Qual Life Res       Date:  1996-12       Impact factor: 4.147

6.  Antibiotic prophylaxis for haematogenous bacterial arthritis in patients with joint disease: a cost effectiveness analysis.

Authors:  P Krijnen; C J Kaandorp; E W Steyerberg; D van Schaardenburg; H J Moens; J D Habbema
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

7.  Use of the EuroQoL among elderly acute care patients.

Authors:  J Coast; T J Peters; S H Richards; D J Gunnell
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

Review 8.  Quality-of-Life measurements for patients taking which drugs? The clinical PCASEE perspective.

Authors:  P Bech
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

9.  Prioritising elective care: a cost utility analysis of orthopaedics in the north west of England.

Authors:  M James; S St Leger; K V Rowsell
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

10.  A longitudinal assessment of the responsiveness of the ICECAP-A in a randomised controlled trial of a knee pain intervention.

Authors:  T Keeley; H Al-Janabi; E Nicholls; N E Foster; S Jowett; J Coast
Journal:  Qual Life Res       Date:  2015-04-18       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.